Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Evaluation of the DOAC-Stop Procedure by LC-MS/MS Assays for Determining the Residual Activity of Dabigatran, Rivaroxaban, and Apixaban.

Slavik L, Jacova J, Friedecky D, Ulehlova J, Tauber Z, Prochazkova J, Hlusi A, Palova M.

Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619872556. doi: 10.1177/1076029619872556.

2.

Addiction to DUSP1 protects JAK2V617F-driven polycythemia vera progenitors against inflammatory stress and DNA damage, allowing chronic proliferation.

Stetka J, Vyhlidalova P, Lanikova L, Koralkova P, Gursky J, Hlusi A, Flodr P, Hubackova S, Bartek J, Hodny Z, Divoky V.

Oncogene. 2019 Jul;38(28):5627-5642. doi: 10.1038/s41388-019-0813-7. Epub 2019 Apr 9.

3.

Multianalyte Determination of NOACs Using LC-MS/MS and Comparison with Functional Coagulation Assays.

Slavik L, Lukes J, Friedecky D, Zhanelova M, Nemcova M, Ulehlova J, Prochazkova J, Hlusi A, Palova M, Vaclavik J.

Clin Lab. 2018 Oct 1;64(10):1611-1621. doi: 10.7754/Clin.Lab.2018.180335.

PMID:
30336535
4.

Thrombin Generation Testing in Patients with Myelofibrosis.

Palova M, Slavik L, Hlusi A, Szotkowski T, Ulehlova J, Divoka M, Navratilova J, Papajik T.

Clin Lab. 2018 Sep 1;64(9):1373-1383. doi: 10.7754/Clin.Lab.2018.180204.

PMID:
30274004
5.

Effect of CALR and JAK2 mutations on the clinical and hematological phenotypes of the disease in patients with myelofibrosis - long-term experience from a single center.

Palova M, Szotkowski T, Hlusi A, Indrak K, Navratilova J, Divoka M, Papajik T.

Neoplasma. 2018;65(2):296-303. doi: 10.4149/neo_2018_170426N313.

PMID:
29534592
6.

Validation of a New Panel of Automated Chemiluminescence Assays for Anticardiolipin Antibodies in the Screening for Antiphospholipid Syndrome.

Janek D, Slavik L, Ulehlova J, Krcova V, Hlusi A, Prochazkova J.

Clin Lab. 2016 Jul 1;62(7):1309-1315. doi: 10.7754/Clin.Lab.2015.151129.

PMID:
28164648
7.

Polymorphism of the Fcγ Receptor II as a Possible Predisposing Factor for Heparin-Induced Thrombocytopenia.

Slavik L, Svobodova G, Ulehlova J, Krcova V, Hlusi A, Prochazkova J, Hutyra M.

Clin Lab. 2015;61(8):1027-32.

PMID:
26427148
8.

Refractory immune thrombocytopenia. Successful treatment with repeated cyclosporine A: two case reports.

Hlusi A, Szotkowski T, Indrak K.

Clin Case Rep. 2015 Jun;3(6):337-41. doi: 10.1002/ccr3.182. Epub 2015 Mar 10.

9.

Detection of clopidogrel resistance using ADP induced aggregometry with specific inhibitor PGE1.

Slavik L, Ulehlova J, Krcova V, Hlusi A, Indrakova J, Hutyra M, Galuszka J, Indrak K.

Clin Lab. 2014;60(9):1475-80.

PMID:
25291943
10.

The advantages and limitations of impedance aggregometry in detection of heparin-induced thrombocytopenia.

Slavik L, Svobodova G, Ulehlova J, Krcova V, Hlusi A, Prochazkova J, Kaletova M, Hrckova Y, Indrak K.

Clin Lab. 2014;60(8):1319-24.

PMID:
25185417
11.

Ibritumomab tiuxetan plus BEAM in refractory diffuse large B-cell lymphoma.

Procházka V, Hluší A.

Haematologica. 2014 Jul;99(7):e108. doi: 10.3324/haematol.2014.107177. No abstract available.

12.

[The occurence of genetic trombophilic markers in patients evaluated for infertility].

Filipčíková R, Březinová J, Oborná I, Blažková Z, Krčová V, Slavík L, Ulehlová J, Hluší A, Bezdičková M.

Ceska Gynekol. 2013 Jan;78(1):73-7. Czech.

PMID:
23607386
13.

Efficacy of rituximab in primary immune thrombocytopenia: an analysis of adult pretreated patients from everyday hematological practice.

Červinek L, Černá O, Čaniga M, Konířová E, Hluší A, Šimkovič M, Pospíšil Z, Čermák J, Kozák T, Mayer J, Doubek M.

Int J Hematol. 2012 Nov;96(5):594-9. doi: 10.1007/s12185-012-1206-7. Epub 2012 Oct 26.

PMID:
23099924
14.

The pathophysiology of endothelial function in pregnancy and the usefulness of endothelial markers.

Slavik L, Prochazkova J, Prochazka M, Simetka O, Hlusi A, Ulehlova J.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Dec;155(4):333-7. doi: 10.5507/bp.2011.031.

15.

[Essential thrombocythaemia and other myeloproliferative disorders with thrombocythaemia treated with Thromboreductin. A report from the database of register for the 1st quarter of 2010].

Penka M, Schwarz J, Ovesná P, Hlusí A, Korístek Z, Doubek M, Dulícek P, Pospísilová D, Kissová J, Buliková A, Pavlík T; CZEMP.

Vnitr Lek. 2010 Jun;56(6):503-12. Czech.

PMID:
20681462
16.

[The results of patients with essentials thrombocythemia and other myeloproliferation-related thrombocythemia--a report of patients treated with Thromboreductin].

Penka M, Schwarz J, Pavlík T, Indrák K, Doubek M, Dulícek P, Pospísilová D, Kissová J, Jonásová A, Jelínková P, Hlusí A, Schutzová M, Cerná O, Brychtová Y, Nováková L, Korístek Z, Segethová J, Vozobulová V, Hadacová I, Hochová I, Voglová J, Walterová L, Bodzásová C, Dusek L.

Vnitr Lek. 2009 Nov;55(11):I-XII. Czech.

PMID:
20017445
17.

Precursor T-lymphoblastic lymphoma as a secondary malignancy in a young patient after successful treatment of acute promyelocytic leukemia.

Szotkowski T, Jarosova M, Faber E, Hubacek J, Hlusi A, Papajik T, Pikalova Z, Kucerova L, Holzerova M, Budikova M, Buriankova E, Plachy R, Potomkova J, Klusova N, Szotkowska R, Indrak K.

Onkologie. 2009 Sep;32(8-9):513-5. doi: 10.1159/000226584. Epub 2009 Jul 23.

PMID:
19745598
18.

[Molecular methods in thrombophilic states diagnostics].

Slavík L, Krcová V, Hlusí A, Procházková J, Ulehlová J.

Vnitr Lek. 2009 Mar;55(3):302-9. Review. Czech.

PMID:
19378863
19.

Molecular pathophysiology of thrombotic states and their impact to laboratory diagnostics.

Slavik L, Krcova V, Hlusi A, Prochazkova J, Prochazka M, Ulehlova J, Indrak K.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009 Mar;153(1):19-25. Review.

20.

[What is the current treatment of patients with essential thrombocytopenia and other myeloproliferations accompanied with thrombocythemia [corrected] and what can be the predictive sign of the risk of thrombosis in such patients--a report from the registry of patients treated by Thromboreductine].

Penka M, Schwarz J, Pavlík T, Pytiĺk R, Doubek M, Dulícek P, Kissová J, Hlusi A, Schutzová M, Cerná O, Brychtová Y, Szotkowski T, Volková Z, Seghetová J, Vozobulová V, Hadacová I, Hochová I, Voglová J, Dusek L.

Vnitr Lek. 2008 Jul-Aug;54(7-8):775-82. Czech. Erratum in: Vnitr Lek. 2008 Dec;54(12):1205.

PMID:
18780577
21.

[Essential thrombocytemia and other myeloproliferations with thrombocytemia in the data of the register of patients treated with Thromboreductin till the end of 2006].

Penka M, Schwarz J, Pavlík T, Pytlík R, Doubek M, Dulícek P, Pospísilová D, Kissová J, Hlusí A, Schützová M, Cerná O, Brychtová Y, Szotkowski T, Volková Z, Seghetová J, Vozobulová V, Hadacová I, Hochová I, Voglová J, Lhotanová T, Bubeník B, Zapletal O, Vránová M, Micaníková M, Dusek L.

Vnitr Lek. 2007 Jun;53(6):653-61. Czech.

PMID:
17702125
22.

[Anagrelide in the treatment of essential thrombocythemia (ET) and other myeloproliferative disorders with thrombocythemia based on data from patient register in the CR].

Penka M, Doubek M, Schwarz J, Pytlík R, Dulícek P, Kissová J, Hlusí A, Vozobulová V, Cerná O, Brychtová Y, Szotkowski T, Volková Z, Seghetová J, Schutzová M, Hadacová I, Hochová I, Voglová J, Siroký O, Belada D, Lhot'anová T, Bubeník B, Vránová M, Micaníková M, Dusek L.

Vnitr Lek. 2006 May;52(5):498-503. Czech.

PMID:
16771099
23.

[Importance of determination of serum beta-2-microglobulin levels in patients with Hodgkin's lymphoma].

Raida L, Papajík T, Hlusí A, Faber E, Urbanová R, Heczko M, Jancíková M, Zapletalová J, Komenda S, Indrák K.

Vnitr Lek. 2002 Feb;48(2):91-5. Czech.

PMID:
11949228
24.

[Comparison of the effectiveness of idarubicin (Zavedos) and mitoxantrone (Refador) in induction therapy of acute myeloid leukemia in elderly patients (55-75) (a prospective multicenter randomized study conducted 1998-2000].

Indrák K, Hubácek J, Mayer J, Voglová J, Jarosová M, Krahulová M, Malý J, Faber E, Penka M, Kmonícek M, Jebavý L, Szotkowski T, Knotková R, Hlusí A, Zapletalová J.

Vnitr Lek. 2001 Sep;47 Suppl 1:48-56. Czech.

PMID:
11693063

Supplemental Content

Support Center